Characterisation of uropathogenic Escherichia coli from children with urinary tract infection in different countries

  • N. L. Ramos
  • D. T. N. Dzung
  • K. Stopsack
  • V. Jankó
  • M. R. Pourshafie
  • M. Katouli
  • A. BraunerEmail author


Uropathogenic Escherichia coli (UPEC) carry many virulence factors, including those involved in long-term survival in the urinary tract. However, their prevalence and role among UPEC causing urinary tract infection (UTI) in children is not well studied. To further understand the virulence characteristics of these bacteria, we investigated the prevalence of antibiotic resistance, antigen 43 genes, curli and cellulose among UPEC in children from different countries. Isolates (n = 337) from five countries were tested for antibiotic susceptibility, phylogenetic groups, prevalence of flu, fluA CFT073, fluB CFT073, curli and cellulose. High prevalence of multidrug resistance and extended spectrum beta lactamase production was found among Iranian and Vietnamese isolates. Resistance was associated with phylogenetic group D while group B2 was associated with fluA CFT073 and fluB CFT073. Fewer Iranian isolates carried fluA CFT073, curli and cellulose. fluB CFT073 was most prevalent among Slovak isolates. Ampicillin and amoxicillin/clavulanic acid resistance was prevalent among fluA CFT073- and fluB CFT073-positive Australian, Iranian and Swedish isolates. Lack of curli and cellulose was associated with resistance among Vietnamese isolates. We conclude that major differences exist in the prevalence of antibiotic resistance among UPEC from different countries. Associations observed between resistance and virulence factors may, in different ways, promote the long-term survival of UPEC in the urinary tract.


Urinary Tract Infection Antibiotic Resistance Phylogenetic Group Recurrent Urinary Tract Infection Ertapenem 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



Nubia L. Ramos was supported by an Australian Postgraduate Award through the University of the Sunshine Coast, Queensland, Australia. Konrad Stopsack held an MD Fellowship of the Boehringer Ingelheim Fonds. This work was also supported by grants from the Swedish Research Council (56X-20356), ALF Project Funding, Grants from the Swedish International Development Cooperation Agency and Karolinska Institutet.

The authors would like to thank Dr László Kovács from the Department of Pediatrics and Dr Ján Koreň from the Department of Microbiology at Comenius University Medical School, Bratislava, and Dr Malieh Talebi from the Department of Microbiology, University of Iran, Tehran, for the collection of isolates in Slovakia and Iran, respectively. We thank Agneta Hilding from the Department of Molecular Medicine, Karolinska Institutet for assistance with statistical analyses.


  1. 1.
    Chakupurakal R, Ahmed M, Sobithadevi DN, Chinnappan S, Reynolds T (2010) Urinary tract pathogens and resistance pattern. J Clin Pathol 63:652–654PubMedCrossRefGoogle Scholar
  2. 2.
    Williams G, Craig JC (2009) Prevention of recurrent urinary tract infection in children. Curr Opin Infect Dis 22:72–76PubMedCrossRefGoogle Scholar
  3. 3.
    Shaikh N, Morone NE, Bost JE, Farrell MH (2008) Prevalence of urinary tract infection in childhood. Pediatr Infect Dis J 27:302–308PubMedCrossRefGoogle Scholar
  4. 4.
    Leroy S, Chalumeau M, Ulinski T, Dubos F, Sergent-Alaoui A, Merzoug V, Ducou-le-Pointe H, Audry G, Gendrel D, Bensman A (2010) Impressive renal damage after acute pyelonephritis in a child. Pediatr Nephrol 25:1365–1368PubMedCrossRefGoogle Scholar
  5. 5.
    Conway PH, Cnaan A, Zaoutis T, Henry BV, Grunmeier RW, Keren R (2007) Recurrent urinary tract infections in children: risk factors and association with prophylactic antimicrobials. JAMA 298:179–186PubMedCrossRefGoogle Scholar
  6. 6.
    Craig JC, Simpson JM, Williams GJ, Lowe A, Reynolds GJ, McTaggart SJ, Hodson EM, Carapetis JR, Cranswick NE, Smith G, Irwig LM, Caldwell PHY, Hamilton S, Roy LP (2009) Antibiotic prophylaxis and recurrent urinary tract infection in children. N Engl J Med 361:1748–1759PubMedCrossRefGoogle Scholar
  7. 7.
    Bitsori M, Maraki S, Kalmanti M, Galanakis E (2009) Resistance against broad-spectrum β-lactams among uropathogens in children. Pediatr Nephrol 24:2381–2386PubMedCrossRefGoogle Scholar
  8. 8.
    Catal F, Bavbek N, Bayrak O, Karabel M, Karabel D, Odemis E, Uz E (2009) Antimicrobial resistance patterns of urinary tract pathogens and rationale for empirical therapy in Turkish children for the years 2000–2006. Int Urol Nephrol 41:953–957PubMedCrossRefGoogle Scholar
  9. 9.
    Cheng C-H, Tsau Y-K, Kuo C-Y, Su L-H, Lin T-Y (2010) Comparison of extended virulence genotypes for bacteria isolated from pediatric patients with urosepsis, acute pyelonephritis, and acute lobar nephronia. Pediatr Infect Dis J 29:736–740PubMedCrossRefGoogle Scholar
  10. 10.
    Ulett GC, Valle J, Beloin C, Sherlock O, Ghigo J-M, Schembri MA (2007) Functional analysis of antigen 43 in uropathogenic Escherichia coli reveals a role in long-term persistence in the urinary tract. Infect Immun 75:3233–3244PubMedCrossRefGoogle Scholar
  11. 11.
    Lüthje P, Brauner A (2010) Ag43 promotes persistence of uropathogenic Escherichia coli isolates in the urinary tract. J Clin Microbiol 48:2316–2317PubMedCrossRefGoogle Scholar
  12. 12.
    Kai-Larsen Y, Lüthje P, Chromek M, Peters V, Wang X, Holm Å, Kadas L, Hedlund K-J, Johansson J, Chapman MR, Jacobson SH, Römling U, Agerberth B, Brauner A (2010) Uropathogenic Escherichia coli modulates immune responses and its curli fimbriae interact with the antimicrobial peptide LL-37. PLoS Pathog 6:e1001010PubMedCrossRefGoogle Scholar
  13. 13.
    Cooke NM, Smith SG, Kelleher M, Rogers TR (2010) Major differences exist in frequencies of virulence factors and multidrug resistance between community and nosocomial Escherichia coli bloodstream isolates. J Clin Microbiol 48:1099–1104PubMedCrossRefGoogle Scholar
  14. 14.
    Johnson JR, Brown JJ (1996) A novel multiply primed polymerase chain reaction assay for identification of variant papG genes encoding the Gal(α1-4)Gal-binding PapG adhesins of Escherichia coli. J Infect Dis 173:920–926PubMedCrossRefGoogle Scholar
  15. 15.
    Clermont O, Bonacorsi S, Bingen E (2000) Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol 66(10):4555–4558PubMedCrossRefGoogle Scholar
  16. 16.
    Restieri C, Garriss G, Locas M-C, Dozois CM (2007) Autotransporter-encoding sequences are phylogenetically distributed among Escherichia coli clinical isolates and reference strains. Appl Environ Microbiol 73:1553–1562PubMedCrossRefGoogle Scholar
  17. 17.
    Roche AJ, McFadden JP, Owen P (2001) Antigen 43, the major phase-variable protein of the Escherichia coli outer membrane, can exist as a family of proteins encoded by multiple alleles. Microbiology 147:161–169PubMedGoogle Scholar
  18. 18.
    van de Sande-Bruinsma N, Grundmann H, Verloo D, Tiemersma E, Monen J, Goossens H, Ferech M, Groups EARSSGaESoACP (2008) Antimicrobial drug use and resistance in Europe. Emerg Infect Dis 14:1722–1730PubMedCrossRefGoogle Scholar
  19. 19.
    Pan Y, Henderson J, Britt H (2006) Antibiotic prescribing in Australian general practice: how has it changed from 1990–91 to 2002–03. Respir Med 100:2004–2011PubMedCrossRefGoogle Scholar
  20. 20.
    Mölstad S, Erntell M, Hanberger H, Melander E, Norman C, Skoog G, Lundborg CS, Söderström A, Torell E, Cars O (2008) Sustained reduction of antibiotic use and low bacterial resistance: 10-year follow-up of the Swedish Strama programme. Lancet Infect Dis 8:125–132PubMedCrossRefGoogle Scholar
  21. 21.
    Mehrgan H, Rahbar M, Arab-Halvaii Z (2010) High prevalence of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a tertiary care hospital in Tehran, Iran. J Infect Dev Ctries 4:132–138PubMedCrossRefGoogle Scholar
  22. 22.
    Duong DV, Binns CW, Le TV (1997) Availability of antibiotics as over-the-counter drugs in pharmacies: a threat to public health in Vietnam. Trop Med Int Health 2:1133–1139PubMedCrossRefGoogle Scholar
  23. 23.
    Gaspari RJ, Dickson E, Karlowsky J, Doern G (2006) Multidrug resistance in pediatric urinary tract infections. Microb Drug Resist 12:126–129PubMedCrossRefGoogle Scholar
  24. 24.
    Bukh AS, Schønheyder HC, Emmersen JMG, Søgaard M, Bastholm S, Roslev P (2009) Escherichia coli phylogenetic groups are associated with site of infection and level of antibiotic resistance in community-acquired bacteraemia: a 10 year population-based study in Denmark. J Antimicrob Chemother 64:163–168PubMedCrossRefGoogle Scholar
  25. 25.
    Johnson JR, Kuskowski MA, Gajewski A, Sahm DF, Karlowsky JA (2004) Virulence characteristics and phylogenetic background of multidrug-resistant and antimicrobial-susceptible clinical isolates of Escherichia coli from across the United States, 2000–2001. J Infect Dis 190:1739–1744PubMedCrossRefGoogle Scholar
  26. 26.
    Narchi H, Al-Hamdani M (2010) Uropathogen resistance to antibiotic prophylaxis in urinary tract infections. Microb Drug Resist 16:151–154PubMedCrossRefGoogle Scholar
  27. 27.
    Mabbett AN, Ulett GC, Watts RE, Tree JJ, Totsika M, Ong CL, Wood JM, Monaghan W, Looke DF, Nimmo GR, Svanborg C, Schembri MA (2009) Virulence properties of asymptomatic bacteriuria Escherichia coli. Int J Med Microbiol 299(1):53–63PubMedCrossRefGoogle Scholar
  28. 28.
    Allsopp LP, Totsika M, Tree JJ, Ulett GC, Mabbett AN, Wells TJ, Kobe B, Beatson SA, Schembri MA (2010) UpaH is a newly identified autotransporter protein that contributes to biofilm formation and bladder colonization by uropathogenic Escherichia coli CFT073. Infect Immun 78(4):1659–1669PubMedCrossRefGoogle Scholar
  29. 29.
    Klemm P, Hjerrild L, Gjermansen M, Schembri MA (2004) Structure-function analysis of the self-recognizing Antigen 43 autotransporter protein from Escherichia coli. Mol Microbiol 51:283–296PubMedCrossRefGoogle Scholar
  30. 30.
    Lüthje P, Brauner A (2010) Putative link between the virulence-associated gene fluA and fluoroquinolone resistance in uropathogenic E. coli. J Clin Microbiol 48:675–676PubMedCrossRefGoogle Scholar
  31. 31.
    Ryu J-H, Beuchat LR (2005) Biofilm formation by Escherichia coli O157:H7 on stainless steel: effect of exopolysaccharide and curli production on its resistance to chlorine. Appl Environ Microbiol 71:247–254PubMedCrossRefGoogle Scholar
  32. 32.
    Uhlich G, Cooke PH, Solomon EB (2006) Analyses of the red-dry-rough phenotype of an Escherichia coli O157:H7 strain and its role in biofilm formation and resistance to antibacterial agents. Appl Environ Microbiol 72:2564–2572PubMedCrossRefGoogle Scholar
  33. 33.
    Andersson DI (2006) The biological cost of mutational antibiotic resistance: any practical conclusions? Curr Opin Microbiol 9:461–465PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2011

Authors and Affiliations

  • N. L. Ramos
    • 1
    • 2
  • D. T. N. Dzung
    • 2
    • 3
  • K. Stopsack
    • 2
  • V. Jankó
    • 4
  • M. R. Pourshafie
    • 5
  • M. Katouli
    • 1
  • A. Brauner
    • 2
    Email author
  1. 1.Faculty of Science, Health and EducationUniversity of the Sunshine CoastMaroochydoreAustralia
  2. 2.Department of Microbiology, Tumour and Cell Biology, Division of Clinical MicrobiologyKarolinska Institutet and Karolinska University HospitalStockholmSweden
  3. 3.Department of BiochemistryHanoi Medical University and Hanoi Medical University HospitalHanoiVietnam
  4. 4.Department of PediatricsComenius University Medical SchoolBratislavaSlovakia
  5. 5.Department of MicrobiologyPasteur Institute of IranTehranIran

Personalised recommendations